Prevention of the ills caused by the ingestion of fat and advanced glycation end products (AGEs) in healthy women.
Conditions
Interventions
The study was a randomized, double-blind, placebo-controlled, crossover clinical trial with 16 ( all the women participate in both groups - placebo and intervention) healthy young women, 18 to 25 year
Dietary supplement
Sponsors
Faculdade de Nutrição da Universidade Federal de Goiás
Faculdade de Nutrição da Universidade Federal de Goiás
Eligibility
Sex/Gender
Female
Age
18 Years to 25 Years
Inclusion criteria
Inclusion criteria: Female; healthy; eutrophic (BMI between 18.5 kg / m2 and 24.9 kg / m2) and age between 18 and 25 years.
Exclusion criteria
Exclusion criteria: Cardiovascular, pulmonary or metabolic diseases; use of anti-inflammatory medications and corticosteroids; food restrictions related to the meal used in the study (potato chips, bacon and Parmesan cheese); pregnant and / or lactating; smoker.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The expected outcome for the present study is 10% reduction in advanced glycation end products (AGE), measured by serum carboxymethyl lysine, and triglycerides concentrations 120 minutes after epigallocatechin-3-gallate administration and AGE-rich meal intake. | — |
Secondary
| Measure | Time frame |
|---|---|
| An improvement in insulin resistance (5%) is expected after (120 min) the epigallocatechin-3-gallate administration and AGE-rich meal intake.;A reduction in insulin resistance (5%) is expected after (120 min) the epigallocatechin-3-gallate administration and AGE-rich meal intake. | — |
Countries
Brazil
Contacts
Public ContactJoão Mota
Faculdade de Nutrição da Universidade Federal de Goiás
Outcome results
None listed